StreetInsider.com News Articles

Form 8-K Ascend Wellness Holdings For: Feb 11

Fri, 13 Feb 2026 16:35:00 -0500

si-local-file:///var/storage/secattach/20260213/26001212.html

Form 8-K Ascend Wellness Holdings For: Feb 11

Fri, 13 Feb 2026 16:35:00 -0500

si-local-file:///var/storage/secattach/20260213/26001212.html

Form 8-K Ascend Wellness Holdings For: Feb 09

Mon, 09 Feb 2026 08:14:00 -0500

si-local-file:///var/storage/secattach/20260209/25965269.html

Form 8-K Ascend Wellness Holdings For: Feb 09

Mon, 09 Feb 2026 08:14:00 -0500

si-local-file:///var/storage/secattach/20260209/25965269.html

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

NEW YORK, Feb. 9, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced preliminary, unaudited results for the fourth quarter and year ended December 31, 2025.

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date

Mon, 09 Feb 2026 08:00:00 -0500

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively

Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million

Balance sheet strength with $86 million cash and no significant debt maturities until 2029

Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET

Form 8-K Ascend Wellness Holdings For: Feb 05

Fri, 06 Feb 2026 16:34:00 -0500

si-local-file:///var/storage/secattach/20260206/25962143.html

Form 8-K Ascend Wellness Holdings For: Feb 05

Fri, 06 Feb 2026 16:34:00 -0500

si-local-file:///var/storage/secattach/20260206/25962143.html

Form EFFECT Ascend Wellness Holdings

Fri, 23 Jan 2026 06:04:00 -0500

si-local-file:///var/storage/secattach/20260123/25883751.html

Form EFFECT Ascend Wellness Holdings

Fri, 23 Jan 2026 06:04:00 -0500

si-local-file:///var/storage/secattach/20260123/25883751.html

Ascend Wellness Holdings Announces Opening of New Dispensary in Englewood, Expanding Ohio Footprint

Wed, 14 Jan 2026 08:00:00 -0500

Englewood, Ohio dispensary to serve medical patients and non-medical customers

NEW YORK, Jan. 14, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today announced the opening of its newest Ohio dispensary located in Englewood, Ohio at 7701 Hoke Road, Englewood, Ohio 45315. The dispensary will begin welcoming medical patients and non-medical customers today, followed by a grand opening on January 16.

Ascend Wellness Holdings Announces Opening of New Dispensary in Englewood, Expanding Ohio Footprint

Wed, 14 Jan 2026 08:00:00 -0500

Englewood, Ohio dispensary to serve medical patients and non-medical customers

Ascend Wellness Holdings Announces Opening of New Dispensary in Englewood, Expanding Ohio Footprint

Wed, 14 Jan 2026 08:00:00 -0500

Englewood, Ohio dispensary to serve medical patients and non-medical customers

Ascend Wellness Holdings Announces Opening of New Dispensary in Englewood, Expanding Ohio Footprint

Wed, 14 Jan 2026 08:00:00 -0500

Englewood, Ohio dispensary to serve medical patients and non-medical customers

Ascend Wellness Holdings Announces Opening of New Dispensary in Englewood, Expanding Ohio Footprint

Wed, 14 Jan 2026 08:00:00 -0500

Englewood, Ohio dispensary to serve medical patients and non-medical customers

Ascend Wellness Holdings Announces Opening of New Dispensary in Englewood, Expanding Ohio Footprint

Wed, 14 Jan 2026 08:00:00 -0500

Englewood, Ohio dispensary to serve medical patients and non-medical customers

Leslie's appoints John Hartmann as independent board director

Thu, 08 Jan 2026 08:30:46 -0500

Leslie's Inc. (NASDAQ: LESL) appointed John Hartmann as an independent director to its board of directors, effective January 7, 2026, according to a company statement. The appointment expands the board from eight to nine members.

Hartmann will serve as a Class III Director and stand for election at the company's 2026 annual meeting of shareholders. He brings nearly 25 years of retail leadership experience across home improvement and home furnishings industries.

The Phoenix-based pool and spa care retailer noted that Hartmann has experience as a C-suite executive at both public and private companies. His previous roles include CEO of Ascend Wellness Holdings,